Pharvaris (PHVS) EBT (2020 - 2026)
Pharvaris (PHVS) posted EBT of -$45.6 million for Q1 2026, up 13.14% on a QoQ basis from -$52.5 million in Q4 2025, and up 5.89% year-over-year from -$43.0 million in Q1 2025.
Pharvaris (PHVS) EBT (2020 - 2026) Analysis & Trends
Pharvaris' EBT history runs 7 years deep, the most recent figure standing at -$45.6 million for Q1 2026.
- Quarterly EBT rose 5.89% year-over-year to -$45.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$192.9 million (down 19.28% YoY) and the FY2025 annual result came in at -$196.3 million, down 36.96% from the prior year.
- EBT was -$45.6 million for Q1 2026 at Pharvaris, up from -$52.5 million in the prior quarter.
- Across five years, EBT topped out at -$10.5 million in Q2 2022 and bottomed at -$52.5 million in Q4 2025.
- A 5-year average of -$33.7 million and a median of -$35.6 million in 2023 frame the typical range for EBT.
- Peak annual rise in EBT reached 42.41% in 2022, while the deepest fall reached 146.94% in 2022.
- Pharvaris' EBT stood at -$40.4 million in 2022, then increased by 11.93% to -$35.6 million in 2023, then declined by 0.74% to -$35.8 million in 2024, then plunged by 46.48% to -$52.5 million in 2025, then advanced by 13.14% to -$45.6 million in 2026.
- Business Quant data shows PHVS's EBT at -$45.6 million in Q1 2026, -$52.5 million in Q4 2025, and -$43.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | -45.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.57 Mn |
| Dec 31, 2025 | -52.47 Mn |
| Sep 30, 2025 | -43.63 Mn |
| Jun 30, 2025 | -51.25 Mn |
| Mar 31, 2025 | -48.43 Mn |
| Dec 31, 2024 | -35.82 Mn |
| Sep 30, 2024 | -45.55 Mn |
| Jun 30, 2024 | -31.94 Mn |
| Mar 31, 2024 | -30.13 Mn |
| Dec 31, 2023 | -35.56 Mn |
| Sep 30, 2023 | -25.53 Mn |
| Jun 30, 2023 | -23.74 Mn |
| Mar 31, 2023 | -24.23 Mn |
| Dec 31, 2022 | -40.37 Mn |
| Sep 30, 2022 | -10.98 Mn |
| Jun 30, 2022 | -10.54 Mn |
| Mar 31, 2022 | -17.94 Mn |
| Dec 31, 2021 | 34,662.07 Bn |
| Sep 30, 2021 | -10.70 Mn |
| Jun 30, 2021 | -18.30 Mn |